Behçet disease associated with myelodysplastic syndrome

Journal of Clinical Rheumatology

Volumn 14, Issue 3, 2008, Pages 169-174

  Lin, Yi Chun ^a   Liang, Toong Hua ^b,c   Chang, Hsiao Ning ^a,d   Lin, Jeong Shi ^d,e   Lin, Hsiao Yi ^a,d,e  

^a Section of Allergy   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Beh et's disease; Chronic myelomonocytic leukemia; Myelodysplastic syndrome; Trisomy 8

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; C REACTIVE PROTEIN; D DIMER; FIBRINOGEN; FRUCTOSE BISPHOSPHATE; HEMOGLOBIN; HEPARIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE; PROSTAGLANDIN E1; TROPONIN I;

ABDOMINAL PAIN; ACROCYANOSIS; ACUTE HEART INFARCTION; ADULT; APPENDECTOMY; ARTICLE; AVASCULAR NECROSIS; BEHCET DISEASE; BLAST CELL; BONE MARROW BIOPSY; BONE MARROW DISEASE; CARDIOPULMONARY ARREST; CASE REPORT; CECUM; CELL INFILTRATION; CEREBRAL SINUS THROMBOSIS; CHROMOSOME ANALYSIS; CHRONIC MYELOMONOCYTIC LEUKEMIA; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CROHN DISEASE; DIARRHEA; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG PULSE THERAPY; DYSERYTHROPOIESIS; DYSGRANULOPOIESIS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEMUR CONDYLE; FEMUR HEAD; FEVER; FINGER; GANGRENE; GENITAL ULCER; GRANULOMA; HEADACHE; HEMICOLECTOMY; HEMOGLOBIN BLOOD LEVEL; HIP; HISTIOCYTE; HUMAN; HUMAN TISSUE; ILEUM; ILEUM RESECTION; INTESTINE BIOPSY; INTESTINE ISCHEMIA; INTESTINE ULCER; JOINT EFFUSION; KARYOTYPE; LEUKOCYTE COUNT; LEUKOCYTOSIS; LYMPHOID CELL; MACROCYTIC ANEMIA; METAPHASE; MONOCYTE; MOUTH ULCER; MYELODYSPLASTIC SYNDROME; NEUTROPHIL COUNT; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; RECURRENT FEVER; RESPIRATORY DISTRESS SYNDROME; SEPTIC SHOCK; SHOCK; SIDE TO SIDE ANASTOMOSIS; SMALL INTESTINE PERFORATION; ST SEGMENT ELEVATION; T WAVE INVERSION; TAIWAN; THORAX PAIN; THROMBOCYTE COUNT; TOE; TRISOMY 8; VASCULITIS; CHROMOSOME 8; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MIDDLE AGED; REVIEW; TRISOMY;

BEHCET SYNDROME; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; TRISOMY;

EID: 48249103136     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3181776bde     Document Type: Article

References (37)

1. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. The Lancet. 1990;335:1078-1080.
2. Sakane T, Takeno M, Suzuki N, et al. Behçet's disease. N Engl J Med. 1999;341:1284-1291.
3. Bennett JM, Catovsky D, Daniel MT, et al. The French-American-British (FAB) Co-operative Group. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982;51:189-199.
4. Ohno E, Ohtsuka E, Watanabe K, et al. Behçet's disease associated with myelodysplastic syndromes. Cancer. 1997;79:262-268.
5. Kimura S, Kuroda J, Akagi T, et al. Trisomy 8 involved in myelodys-plasatic syndromes as a risk factor for intestinal ulcers and thrombosis-Behçet's disease. Leuk Lymphoma. 2001;42:115-121.
6. Yamato K. Successful cord blood stem cell transplantation for myelodys-plastic syndrome with Behçet's disease. Int J Hematol. 2003;77:82- 85.
7. Bangerter M, Griesshammer MV, Tirpitz C, et al. Myelodysplastic syndrome with monosomy 7 after immunosuppressive therapy in Beh-çet's disease. Scand J Rheumatol. 1999;28:117-119.
8. Handa T, Arai Y, Mitati K. Myelodysplastic syndrome associated with intestinal tract-type Behçet's disease characterized by an esophageal ulcer (Japanese). Rinsho Ketsueki-Japanese J Clin Hematology. 2004; 45:1135-1137.
9. Ogawa H, Kuroda T, Inada M, et al. Intestinal Behçet's disease associated with myelodysplastic syndrome with chromosomal trisomy 8-a report of two cases and a review of the literature. Hepato-Gastroenterol. 2001;48:416-420.
10. Karuvannur S, Lipstein E, Brennessel D, et al. Atypical Behçet's syndrome in a patient with myelodyspplstic syndrome. Mt Sinai J Med. 2001;68:403-405.
11. Oh EJ, Yoon JS, Park YJ, et al. Behçet's disease associated with myelo-dysplastic syndrome: a case report. J Korean Med Sci. 1999;14:685- 687.
12. Tanaka E, Nishinarita M, Uesato M, et al. A case of intestinal Behçet's disease with abnormal ossification complicated by myelodysplastic syndrome, symptoms revealed after the perforation of ileum ulcer (Japanese). Ryumachi. 2000;40:711-718.
13. Tomonari A, Tojo A, Takahashi T, et al. Resolution of Behçet's disease after HLA-mismatched unrelated cord blood transplantation for myelo-dysplastic syndrome. Ann Hematol. 2004;83:464-466.
14. Bang D, Lee JH, Lee ES, et al. Epidemiologic and clinical survey of Behçet's disease in Korea: the first multicenter study. J Korean Med Sci. 2001;16:615-618.
15. Chen B, Zhao W-L, Jin J, et al. Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries. Leukemia. 2005;19:767-775.
16. Matsushima T, Handa H, Yokohama A, et al. Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosino-philia or basophilia. Blood. 2003;101:3386-3390.
17. Lee DS, Kim SH, Seo EJ, et al. Predominance of trisomy 1q in myelodysplastic syndromes in Korean: is there an ethnic difference? A 3-year multi-center study. Cancer Genet Cytogenet. 2002;132:97-101.
18. Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Cytogenetics of myelodysplastic syndromes. Blood. 1997;89:2079-2088.
19. Suzuki Kurokawa M, Suzuki N. Bechet disease. Clin Exp Med 2004;4: 10-20.
20. Nakae K, Masaki F, Hashimoto T, et al. Recent epidemiological features of Behçet's disease in Japan. In: Wechsler B, Godeau P, eds. Behçet's disease. Amsterdam: Excerpta Medica; 1993:145-151.
21. Zouboulis CC, Kotter I, Djawari, et al. Epidemiological features of Ada-mantiades-Behçet's disease in Germany and in Europe. Yonsei Med J. 1997;38:411-422.
22. Oscier DG. ABC of clinical haematology. The myeodysplastic syndromes. BMJ 1997;314:883-886.
23. Smith SM, Le Beau MM, Huo D, et al. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood. 2003;102:43-52.
24. Takeuchi F, Takeuchi A. Chromosome aberration in lymphocytes from Behcet's disease. J Rheumatol. 1991;18:1207-1210.
25. Voulgarelis M, Giannouli S, Ritis K, et al. Myelodysplasia-associated autoimmunity: clinical and pathophysiologic concepts. Eur J Clin Invest. 2004;34:690-700.
26. Raza A, Gezer S, Mundle S, et al. Apoptosis in bone marrow biopsy samples involving stromal and hematopoetic cells in 50 patients with myelodysplastic syndromes. Blood. 1995;86:268-276.
27. Gersuk GM, Beckham C, Loken MR, et al. A role for tumor necrosis factor-α, Fas and Fas-ligand in marrow failure associated with myelodysplastic syndrome. Br J Haematol. 1998;103:176-188.
28. Sloand EM, Kim S, Fuhrer M, et al. Fas-mediated apoptosis is important in regulating cell replication and death in trisomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities. Blood. 2002;100: 4427-4432.
29. Giannouli S, Voulgarelis M, Zintzaras E, et al. HM. Autoimmune phenomena in myelodysplastcis syndromes: a 4-yr prospective study. Rheumatology. 2004;43:626-632.
30. Todaro M, Zerilli M, Triolo G, et al. NF-κB protects Behηnet's disease T-cells against CD95-induced apoptosis up-regulating antiapoptotic proteins. Arthritis Rheum. 2005;52:2179 -2191.
31. Kawakami T, Ohashi S, Kawa Y, et al. Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of sweet syndrome and patients with active Behçet's disease. Arch Dermatol. 2004;140:570-574.
32. Sakane T, Suzuki N, Nagafuchi H. Etiopathology of Behçet's disease: immunological aspects. Yonsei Med J. 1997;38:350-358.
33. Mege JL, Dilsen N, Sangruedolce V, et al. Overproduction of monocyte derived tumor necrosis factor alpha (TNF-α), interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behηet's disease. A comparative study with familial mediterranean fever and healthy subjects. J Rheumatol. 1993;20:1544-1549.
34. Sutherland GR, Baker E, Fernandez KE, et al. The gene for human interleukin 7 (IL-7) is at 8q12-13. Hum Genet. 1989;82:371-372.
35. Watanabe M, Uveno Y, Yamazaki M, et al. Mucosal IL-7-mediated immune responses in chronic colitis-IL-7 transgenic mouse model. Immunol Res. 1999;20:251-259.
36. Lee SH, Shin MS, Kim HS, et al. Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma. Oncogene. 2001;20:399-403.
37. Watt R, Stanton LW, Marcu KB, et al. Nucleotide sequence of cloned cDNA of human c-myc oncogene. Nature. 1983;303:725-728.